Avestar Capital
BSX icon

Avestar Capital’s Boston Scientific BSX Stock Holding History

Avestar Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$565K Sell
12,954
-2,097
-14% -$97.1K 0.04% 335
2026
Q2 		$642K Sell
15,051
-1,724
-10% -$93.6K 0.04% 321
2026
Q1 		$1.05M Buy
16,775
+1,738
+12% +$139K 0.07% 214
2025
Q4 		$1.43M Sell
15,037
-501
-3% -$49.1K 0.09% 164
2025
Q3 		$1.52M Sell
15,538
-2,693
-15% -$279K 0.1% 157
2025
Q2 		$1.96M Buy
18,231
+1,332
+8% +$135K 0.13% 120
2025
Q1 		$1.7M Sell
16,899
-482
-3% -$48.5K 0.15% 120
2024
Q4 		$1.55M Buy
17,381
+4,984
+40% +$439K 0.13% 125
2024
Q3 		$1.04M Buy
12,397
+1,158
+10% +$91.3K 0.11% 150
2024
Q2 		$866K Sell
11,239
-1,122
-9% -$82.1K 0.09% 170
2024
Q1 		$847K Buy
12,361
+2,074
+20% +$133K 0.09% 171
2023
Q4 		$595K Buy
10,287
+892
+9% +$47.6K 0.07% 177
2023
Q3 		$496K Buy
9,395
+20
+0.2% +$1.05K 0.07% 170
2023
Q2 		$507K Buy
9,375
+1,033
+12% +$54K 0.08% 149
2023
Q1 		$417K Buy
8,342
+560
+7% +$26.4K 0.07% 167
2022
Q4 		$360K Sell
7,782
-225
-3% -$9.7K 0.07% 180
2022
Q3 		$310K Sell
8,007
-680
-8% -$27.3K 0.08% 176
2022
Q2 		$324K Buy
8,687
+1,936
+29% +$78.8K 0.08% 194
2022
Q1 		$299K Buy
6,751
+408
+6% +$17.7K 0.05% 315
2021
Q4 		$269K Buy
6,343
+1,026
+19% +$43.1K 0.03% 368
2021
Q3 		$231K Buy
5,317
+148
+3% +$6.55K 0.03% 398
2021
Q2 		$221K Buy
+5,169
New +$217K 0.03% 401
2019
Q3 		– Sell
-159
Closed -$5K – 262
2019
Q2 		$5K Hold
159
– – ﹤0.01% 576
2019
Q1 		$4K Hold
159
– – ﹤0.01% 587
2018
Q4 		$4K Hold
159
– – ﹤0.01% 551
2018
Q3 		$4K Sell
159
-4
-2% -$140 ﹤0.01% 564
2018
Q2 		$2K Sell
163
-22
-12% -$664 ﹤0.01% 666
2018
Q1 		$3K Buy
185
+29
+19% +$788 ﹤0.01% 590
2017
Q4 		$2K Buy
+156
New +$4.3K ﹤0.01% 617

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Avestar Capital's BSX Position: Q3 2026 in Review

Avestar Capital reduced its Boston Scientific (BSX) stake by 14% in Q3 2026, selling an estimated $97.1K and leaving 12,954 shares worth $565K. The position accounts for 0.04% of the portfolio, ranked #335.

Avestar Capital first reported a position in BSX in Q4 2017 and has held it in 29 quarters since. The position peaked at $1.96M in Q2 2025. 558 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Avestar Capital held 12,954 shares of Boston Scientific worth $565K as of Q3 2026.
  • Avestar Capital sold 2,097 Boston Scientific shares in Q3 2026, an estimated $97.1K.
  • Boston Scientific made up 0.04% of Avestar Capital's portfolio in Q3 2026, its #335 holding.
  • Avestar Capital first reported a position in Boston Scientific in Q4 2017 and has held it in 29 quarters since.
  • Avestar Capital's Boston Scientific position peaked at $1.96M in Q2 2025.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Avestar Capital's 13F filing for Q3 2026, filed 28 Oct 2026.